Jan 10, 2026 · 44 min
Cramer weighs rally momentum against health care dealmaking
Mad Money w/ Jim Cramer 1/9/26
The episode connects a broad market advance with the policy shifts, biotech transactions, and AI-driven drug development that could reshape health care investing.
- 1Cramer sees opportunities across recovering consumer brands, technology stocks, and companies positioned for renewed growth.
- 2Lisa Gill identifies biotech dealmaking, insurer policy changes, and pharmaceutical mergers as central themes for health care investors.
- 3The discussion links nuclear power and a possible Venezuelan oil revival to the energy demands and opportunities ahead.
Don't miss
Lisa Gill and Jim Cramer map how friendlier biotech dealmaking, insurer policy changes, and AI could reshape health care investing.
The brief
Jim Cramer opens with a broad market rally and previews the J.P. Morgan Health Care Conference, where executive interviews may reveal strategic shifts.
His stock calls span Cloudflare, Cheesecake Factory, SharkNinja, Ulta Beauty, and Kimberly-Clark, with recovery potential and valuation driving the debate.
Lisa Gill joins Cramer to examine biotech dealmaking, insurer and Medicare Advantage policy changes, pharmaceutical M&A, and AI’s role in drug development.
The lightning round moves through lithium, quantum computing, energy, logistics, solar, and software while Cramer warns investors to avoid margin risk.
The episode closes by connecting nuclear power’s potential corporate demand with the possibility of renewed oil investment in Venezuela.
What was said on this episode
36 statements · 29 positive · 6 negative · 1 neutral
Apple and NVIDIA are operating strongly and generating substantial profits.
“I think both Apple and NVIDIA, the companies, are humming along, making a lot of money.”
Listen at 1:18
Investors should own Apple and NVIDIA rather than trade them.
“I say own Apple and own NVIDIA. Don't trade them.”
Listen at 1:50
The J.P. Morgan Health Care Conference can move markets.
“It's a market mover.”
Listen at 2:42
The December CPI report will not be weak.
“I don't think the CPI will be weak.”
Listen at 2:58
Delta will report a strong quarterly result.
“I expect a fine quarter from Delta as it's arguably the best run airline.”
Listen at 4:16
Citigroup has substantially improved operationally.
“Citigroup. It's gone from ugly duckling to beautiful swan.”
Listen at 4:51
Goldman Sachs and Morgan Stanley will report increased results.
“I expect both numbers. I expect number increases for both. Goldman and Morgan Stanley.”
Listen at 5:56
Taiwan Semiconductor will report an exceptionally strong quarter.
“It should be a monster quarter”
Listen at 6:35
Strong initial earnings could improve the market tone going forward.
“The bottom line, a strong start to earnings season could lead to a nice tone going forward.”
Listen at 7:53
Investors should add modestly to Cloudflare after its decline.
“Gregory, I think you buy a little more here.”
Listen at 9:25
Cheesecake Factory will approach its all-time highs.
“I think it's going to make a run at all time highs.”
Listen at 9:54
Cheesecake Factory is undervalued relative to its quality and growth.
“That's way too cheap for a very high quality, still growth company”
Listen at 9:59
SharkNinja could gain substantially if tariffs are struck down.
“Shark Ninja could have a lot more upside”
Listen at 17:52
SharkNinja is a high-quality appliance company that repeatedly beats estimates.
“Shark Ninja is a terrific consumer appliances company with a proven track record of beating the estimates.”
Listen at 18:17
Investors should buy SharkNinja at its current price.
“That's why I'd be a buyer right here, by the way.”
Listen at 18:33
Ulta Beauty's stock has further upside after its rally.
“I'm telling you, people, it's not done.”
Listen at 20:28
Investors can still buy Ulta Beauty for exposure to its improving business.
“I still think you can buy all to hear and get some exposure to this excellent story”
Listen at 24:39
A Supreme Court tariff reversal would raise the unnamed stock by 25 points.
“If you get a tariff overturned from the Supreme Court, this stock's going to go up 25 points.”
Listen at 25:58
Investors should continue holding the tariff-exposed stock.
“Let's just hold on to it for now”
Listen at 26:04
“I think it seems very intriguing to me here at 13 times earnings”
Listen at 27:01
Biotech deal activity may increase around the conference.
“I think there's a lot of expectations around perhaps parties coming together.”
Listen at 28:46
Drug distributors reduce costs for the overall healthcare system.
“drug distributors are incredibly important and save dollars to the overall health care system”
Listen at 29:40
CVS can continue delivering strong performance in 2026.
“I really think that CBS, which is one of our favorite names going into 26, can continue to deliver.”
Listen at 32:20
The current administration is more receptive to biotech transactions than Biden's administration.
“this administration is much more open to transactions than what the Biden administration was open to”
Listen at 33:11
Healthcare companies will discuss AI's potential to improve efficiency and drug development speed.
“I think everybody is going to be talking about can I truly create more efficiency? Can they speed up the process around drug development?”
Listen at 34:03
Albemarle is safer than Lithium Americas for lithium exposure.
“Even though it's up a lot, it's a much safer stock.”
Listen at 35:21
Investors could buy more Talon Energy after its decline.
“I actually would be inclined to buy some here.”
Listen at 36:41
Investors should avoid enterprise software such as SailPoint.
“I just do not want to be in anything like that.”
Listen at 36:56
Investors in logistics should prefer FedEx.
“If you're going to be in that business, you want to be in FedEx.”
Listen at 37:28
First Solar is unsuitable for a margin-financed position.
“First Solar is not good enough to be there.”
Listen at 38:09
The investor should sell First Solar to limit losses.
“you're going to have to cut your losses.”
Listen at 38:14
Amphenus Technologies is a promising speculative investment after its pullback.
“I think you have something there. It's a nice spec and it's come down. I am going to say that that's a good one.”
Listen at 38:49
Investors should buy rather than sell Arm Holdings.
“I think I'm a buyer, not a seller.”
Listen at 39:28
A successful Trump-backed Venezuelan revival would increase oil supply and sharply reduce crude prices.
“if Trump's successful, Venezuela will start pumping a lot more oil and the price of crude will plummet.”
Listen at 40:36
Meta is purchasing electricity from three Vistra nuclear plants.
“Meta's buying electricity from three Vistra plants, nuclear power plants.”
Listen at 40:54
“I wouldn't put money on it.”
Listen at 43:28
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Weekly email
State of the Pod, every Monday
The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.